facebook
twitter
rss
account
search
search
 

Cancer aspirin trials promising

April 27, 2012 at 12:07 AM   |   Comments

DALLAS, April 27 (UPI) -- Aspirin, an over-the-counter drug since 1897, not only has cardiac benefits but may also be a weapon against cancer, a U.S. oncologist said.

Dr. Kevin Choe, an oncologist at the University of Texas Southwestern Medical Center in Dallas, said several studies suggest taking aspirin daily can reduce the risk of cancer or prevent the disease from spreading in those who are already affected.

"We're not quite ready to recommend routine aspirin use in those diagnosed with cancer," Choe said in a statement. "It is premature to say that aspirin should be used in a standard-therapy way in all patients with cancer. But the results are encouraging."

Researchers at the University of Oxford reported that after three years of daily aspirin use, study participants had a risk reduction of almost 25 percent of developing cancer when compared to a control group not taking aspirin.

The study found after five years, the risk of dying of cancer was reduced by 37 percent for those taking aspirin, Choe said.

© 2012 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
trending
2014: The Year in Music [PHOTOS]

2014: The Year in Music [PHOTOS]

Most Popular
1
New research explains insomnia prevalence among elderly
2
New research details rare cancer that killed Bob Marley
3
Yoga guru BKS Iyengar dies at 95
4
New data shows Melbourne is most well-rested city in the world
5
Daughters more likely than sons to care for elder parents
Trending News
Video
x
Feedback